Five Quick-Takes from the ADA 77th Scientific Sessions
Insulin Nation
JUNE 13, 2017
A presentation of several studies on SGLT2 and SGLT1 drugs as an addition to insulin therapy drew a large crowd, as well as a few appreciative murmurs from researchers when modest improvement in A1C scores were announced. Researchers also presented separate findings on metformin and GLP-1 drugs for people with Type 1 diabetes.
Let's personalize your content